Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Re-compensation and Its Clinical Characteristics in Treatment-naïve HBV Decompensated Cirrhosis on Antiviral Therapy

NCT05086536 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT05086536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05086536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Re-compensation and Its Clinical Characteristics in Treatment-naïve HBV Decompensated Cirrhosis on Antiviral Therapy
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2021
Completion date
December 30, 2022
Enrollment
600 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated cirrhosis, hepatitis b